Last month Moderna began clinical trials for a booster dose specifically designed to target Omicron but initial results from studies in monkeys show the Omicron-specific shot may not offer stronger protection than a new dose of the existing vaccine
from mint - Science https://ift.tt/Qfl8IHy
https://ift.tt/Ujxtz3f
from mint - Science https://ift.tt/Qfl8IHy
https://ift.tt/Ujxtz3f
إرسال تعليق